Holborn Wells, a UK-based healthcare focused company which recently established an IVD business unit in India has concluded a joint venture with SpeedBio to establish IVD manufacturing unit in India.
As per a joint statement by Sudhanshu Srivastava, CEO, Holborn Wells India and Santosh Pandey, CEO, SpeedBio India, “The new venture is in line with Government’s ‘Made in India’ initiative which will see the nation emerge as a major player in the provision of quality IVD products in a global supply chain. We believe that through the convergence of this supply chain and availability of resources we have at our disposal, we can rapidly expand to emerging markets and provide high-quality IVD products at reduced price points as a result of considered innovation.”
According to a statement, “Both parties are expected to invest a total of 1 million USD over the coming months to establish the Holborn SpeedBio brand as a leading IVD provider for the market. The newly formed Joint Venture company expects to exceed revenues of over 50 million USD in coming years creating jobs and research facilities across India and United Kingdom. The newly formed joint venture intends to launch and manufacture a portfolio of over 150 IVD products to market within the next year.”
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.